Lv41
590 积分 2023-06-19 加入
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
5分钟前
求助中
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
8分钟前
待确认
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
3小时前
待确认
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
1个月前
已完结
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
2个月前
已完结
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
2个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2个月前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2个月前
已完结
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial
2个月前
已完结
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
2个月前
已完结
皖公网安备34019202002308
